Early Development Deals: Ipsen's Strategy For Biomarker-Driven Success

Ipsen Is On The Lookout For Pre-Clinical Assets That Are Associated With Biomarkers

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.